Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden

Autor: Banefelt, J., Liede, A., Mesterton, J., Stålhammar, J., Hernandez, R.K., Sobocki, P., Persson, B.-E.

Publikováno v: In Cancer Epidemiology August 2014 38(4):442-447

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension.

Autor: Kjeldsen, S. E.¹, Stålhammar, J.², Hasvold, P.³, Bodegard, J.³, Olsson, U.⁴, Russell, D.⁵

Publikováno v: Journal of Human Hypertension. Apr2010, Vol. 24 Issue 4, p263-273. 11p. 1 Diagram, 2 Charts, 5 Graphs.

Written communication from specialists to general practitioners in cancer care: What are the expectations and how are they met?

Autor: Stålhammar J (AUTHOR), Holmberg L (AUTHOR), Svärdsudd K (AUTHOR), Tibblin G (AUTHOR)

Publikováno v: Scandinavian Journal of Primary Health Care. 09/2/198, Vol. 16 Issue 3, p154-159. 6p.

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients

Autor: Hasvold, Lars Pål, Bodegard, Johan, Thuresson, Marcus, Stålhammar, J., Hammar, N., Sundstrom, J, Russell, David, Kjeldsen, Sverre Erik

Publikováno v: Hasvold, Lars Pål Bodegard, Johan Thuresson, Marcus Stålhammar, J. Hammar, N. Sundstrom, J Russell, David Kjeldsen, Sverre Erik . Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients. Jo
Jo

Externí odkaz: http://hdl.handle.net/10852/60088
https://www.duo.uio.no/bitstream/handle/10852/60088/2/jhh201443.pdf